The FDA rapped Korean drugmaker Huons for lackluster testing procedures and laboratory controls observed during an inspection.
Source: Drug GMP Report
The FDA rapped Korean drugmaker Huons for lackluster testing procedures and laboratory controls observed during an inspection.
Source: Drug GMP Report